170 related articles for article (PubMed ID: 29066886)
1. Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor.
Xu Y; Asghar S; Gao S; Chen Z; Huang L; Yin L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7337-7350. PubMed ID: 29066886
[TBL] [Abstract][Full Text] [Related]
2. Chitosan hydrochloride/hyaluronic acid nanoparticles coated by mPEG as long-circulating nanocarriers for systemic delivery of mitoxantrone.
Wang J; Asghar S; Yang L; Gao S; Chen Z; Huang L; Zong L; Ping Q; Xiao Y
Int J Biol Macromol; 2018 Jul; 113():345-353. PubMed ID: 29486258
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone-loaded chitosan/hyaluronate polyelectrolyte nanoparticles decorated with amphiphilic PEG derivates for long-circulating effect.
Wang J; Asghar S; Jin X; Chen Z; Huang L; Ping Q; Zong L; Xiao Y
Colloids Surf B Biointerfaces; 2018 Nov; 171():468-477. PubMed ID: 30077147
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells.
Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y
Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.
Ling G; Zhang T; Zhang P; Sun J; He Z
Drug Dev Ind Pharm; 2016 Aug; 42(8):1351-9. PubMed ID: 26754913
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.
Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q
Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of docetaxel and verapamil by reduction-sensitive PEG-PLGA-SS-DTX conjugate micelles to reverse the multi-drug resistance of breast cancer.
Guo Y; He W; Yang S; Zhao D; Li Z; Luan Y
Colloids Surf B Biointerfaces; 2017 Mar; 151():119-127. PubMed ID: 27988472
[TBL] [Abstract][Full Text] [Related]
8. Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride.
Zhang P; Ling G; Pan X; Sun J; Zhang T; Pu X; Yin S; He Z
Nanomedicine; 2012 Feb; 8(2):185-93. PubMed ID: 21704599
[TBL] [Abstract][Full Text] [Related]
9. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
Abo Mansour HE; El-Batsh MM; Badawy NS; Mehanna ET; Mesbah NM; Abo-Elmatty DM
Hum Exp Toxicol; 2020 Nov; 39(11):1528-1544. PubMed ID: 32519553
[TBL] [Abstract][Full Text] [Related]
10. Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.
Ling G; Zhang T; Zhang P; Sun J; He Z
Int J Nanomedicine; 2016; 11():4077-91. PubMed ID: 27601896
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.
Dong Y; Liao H; Yu J; Fu H; Zhao D; Gong K; Wang Q; Duan Y
J Nanobiotechnology; 2019 Dec; 17(1):125. PubMed ID: 31870362
[TBL] [Abstract][Full Text] [Related]
12. [Tumor cell targetability of folate receptor-mediated mitoxantrone albumin nanoparticles].
Zhang LK; Hou SX; Mao SJ; Wei DP; Song XR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):77-9. PubMed ID: 16468648
[TBL] [Abstract][Full Text] [Related]
13. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance.
Wang F; Zhang D; Zhang Q; Chen Y; Zheng D; Hao L; Duan C; Jia L; Liu G; Liu Y
Biomaterials; 2011 Dec; 32(35):9444-56. PubMed ID: 21903258
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
Lu B; Xiong SB; Yang H; Yin XD; Chao RB
Eur J Pharm Sci; 2006 May; 28(1-2):86-95. PubMed ID: 16472996
[TBL] [Abstract][Full Text] [Related]
16. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
Baek JS; Cho CW
Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
[TBL] [Abstract][Full Text] [Related]
17. Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations.
Zafar S; Negi LM; Verma AK; Kumar V; Tyagi A; Singh P; Iqbal Z; Talegaonkar S
Int J Pharm; 2014 Dec; 477(1-2):454-68. PubMed ID: 25445525
[TBL] [Abstract][Full Text] [Related]
18. Dual agent loaded PLGA nanoparticles enhanced antitumor activity in a multidrug-resistant breast tumor eenograft model.
Chen Y; Zheng XL; Fang DL; Yang Y; Zhang JK; Li HL; Xu B; Lei Y; Ren K; Song XR
Int J Mol Sci; 2014 Feb; 15(2):2761-72. PubMed ID: 24552875
[TBL] [Abstract][Full Text] [Related]
19. Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer.
Qiao H; Zhu Z; Fang D; Sun Y; Kang C; Di L; Zhang L; Gao Y
J Drug Target; 2018 Jan; 26(1):75-85. PubMed ID: 28583001
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. I: Formulation and in vitro characterization.
Lu B; Xiong SB; Yang H; Yin XD; Zhao RB
Int J Pharm; 2006 Jan; 307(2):168-74. PubMed ID: 16316729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
